The science is clear: emissions need to fall 45% by 2030 to avoid the worst climate impacts, states the UN Climate Change convention.

As the climate crisis escalates, so does scrutiny of how companies are addressing environmental sustainability challenges, and new regulations and mandatory sustainability reporting are shaping the way global supply chains operate, promoting environmental responsibility. 

In this white paper, we take a look at some of the key sustainability reporting frameworks and standards that pharma organisations can use to report on their environmental performance, these regulations and initiatives are evolving to facilitate sustainable supply chain operations.

Download this white paper to understand:

  • The key environmental sustainability regulations and what they mean for the pharma industry
  • The latest corporate sustainability reporting directives
  • Next steps for supply chain sustainability
  • Key dates summary

DOWNLOAD THE WHITE PAPER

News, Events & Insights

Here’s what we have been up to

Benefits of Automating The Data Collection Process Across Your Supply Chain

Managing a global supply chain with multiple partners adds layers of complexity and potential for errors, as disparate systems and lack of integration...

Veratrak to lead panel discussion at Logipharma 4.0 Connect, 20-21 Nov. 2024

We are delighted to announce our attendance at LogiPharma 4.0 Connect 2024, taking place in Montreux, Switzerland, on November 20-21. Held at the Fair...

Unveiling the Pharma Industry's Scope 3 Emissions Benchmark Analysis

In an era of increasing environmental consciousness, the pharmaceutical industry finds itself at a critical juncture. With the implementation of the E...

5 Key Trends Shaping the CDMO Industry in 2024

Ahead of the CPHI conference taking place in Milan 8-10 October, we take a look at 5 key trends that are shaping the CDMO (Contract Development and Ma...